- cafead   Jun 21, 2023 at 12:02: PM
via A 20,000-subject clinical trial of Exact Sciences’ next-generation colorectal cancer test has met its primary endpoints, positioning the company to file to sell the diagnostic in the U.S. this year.
article source
article source